{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:56:05Z","timestamp":1768528565044,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s11892-005-0019-y","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T19:30:27Z","timestamp":1179862227000},"page":"254-259","source":"Crossref","is-referenced-by-count":76,"title":["Adiponectin: Protection of the endothelium"],"prefix":"10.1007","volume":"5","author":[{"given":"Karen S. L.","family":"Lam","sequence":"first","affiliation":[]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"19_CR1","first-page":"1171","volume":"141","author":"EB Rimm","year":"1995","unstructured":"Rimm EB, Stampfer MJ, Giovannucci E, et al.: Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidmiol 1995, 141:1171\u20131127.","journal-title":"Am J Epidmiol"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.280.21.1843","volume":"280","author":"KM Rexrode","year":"1998","unstructured":"Rexrode KM, Carey VJ, Hennekens CH, et al.: Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280:2284\u20132285.","journal-title":"JAMA"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/oby.2004.224","volume":"12","author":"GN Thomas","year":"2004","unstructured":"Thomas GN, Ho SY, Lam KSL, et al.: Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 2004, 12:1805\u20131813.","journal-title":"Obes Res"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"14","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, et al.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 14:1752\u20131761.","journal-title":"J Clin Invest"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.C200251200","volume":"277","author":"N Kubota","year":"2002","unstructured":"Kubota N, Terauchi Y, Yamauchi T, et al.: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002, 277:25863\u201325866.","journal-title":"J Biol Chem"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","volume":"277","author":"M Matsuda","year":"2002","unstructured":"Matsuda M, Shimomura I, Sata M, et al.: Role of adiponectin in preventing vascular stenosis: the missing link of adipovascular axis. J Biol Chem 2002, 277:37487\u201337491.","journal-title":"J Biol Chem"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1074\/jbc.M209033200","volume":"278","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Waki H, et al.: Globular adiponectin protected ob\/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J Biol Chem 2003, 278:2461\u20132468.","journal-title":"J Biol Chem"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","volume":"23","author":"M Kumada","year":"2003","unstructured":"Kumada M, Kihar S, Sumitsuji S, et al.: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85\u201389.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","volume":"291","author":"T Pischon","year":"2004","unstructured":"Pischon T, Girman CJ, Hotamisligil GS, et al.: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730\u20131737.","journal-title":"JAMA"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-004-1597-y","volume":"48","author":"T Costacou","year":"2005","unstructured":"Costacou T, Zgibor JC, Evans RW, et al.: The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2005, 48:41\u201348.","journal-title":"Diabetologia"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.54.2.534","volume":"54","author":"MB Schulze","year":"2005","unstructured":"Schulze MB, Shai EB, Rimm EB, et al.: Adiponectin and future coronary heart disease events among men and type 2 diabetes. Diabetes 2005, 54:534\u2013539.","journal-title":"Diabetes"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2002-021883","volume":"88","author":"M Shimabukuro","year":"2003","unstructured":"Shimabukuro M, Higa N, Asahi T, et al.: Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003, 88:3236\u20133240.","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.HYP.0000083488.67550.B8","volume":"42","author":"N Ouchi","year":"2003","unstructured":"Ouchi N, Ohishi M, Kihara S, et al.: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003, 42:231\u2013239. A very good summary of the metabolic and vascular actions of adiponectin.","journal-title":"Hypertension"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jc.2003-031012","volume":"89","author":"KCB Tan","year":"2004","unstructured":"Tan KCB, Xu A, Chow WS, et al.: Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 2004, 89:765\u2013769.","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1002\/pmic.200400826","volume":"4","author":"Y Wang","year":"2004","unstructured":"Wang Y, Lu G, Wong WPS, et al.: Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics 2004, 4:3933\u20133944. A good source of information on the structure-function relationship of adiponectin.","journal-title":"Proteomics"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, et al.: Plasma concentrations of a novel, adipose-specific, protein adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595\u20131599.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"UB Pajvani","year":"2004","unstructured":"Pajvani UB, Hawkins M, Coombs TP, et al.: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement of insulin sensitivity. J Biol Chem 2004, 279:12152\u201312162.","journal-title":"J Biol Chem"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/01.RES.0000119921.86460.37","volume":"94","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi H, Ouchi N, Kihara S, et al.: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004, 94:e27-e31.","journal-title":"Circ Res"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","volume":"280","author":"A Xu","year":"2005","unstructured":"Xu A, Chan KW, Hoo RLC, et al.: Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005, 280:18073\u201318080.","journal-title":"J Biol Chem"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"18341","DOI":"10.1074\/jbc.M501149200","volume":"208","author":"Y Wang","year":"2005","unstructured":"Wang Y, Lam KSL, Xu JY, et al.: Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization dependent manner. J Biol Chem 2005, 208:18341\u201318347.","journal-title":"J Biol Chem"},{"key":"19_CR21","first-page":"867","volume-title":"Joslin\u2019s Diabetes Mellitus","author":"EP Feener","year":"2005","unstructured":"Feener EP, Dzau VJ: Pathogenesis of cardiovascular diseases indiabetes. In Joslin\u2019s Diabetes Mellitus. Edited by Kahn CR, et al. Philadelphia: Lippincott Williams & Wilkins; 2005:867\u2013884."},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/diabetes.47.6.945","volume":"47","author":"U Chakravarthy","year":"1998","unstructured":"Chakravarthy U, Hayes RG, Stitt AW, et al.: Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 1998, 47:945\u2013952.","journal-title":"Diabetes"},{"key":"19_CR23","first-page":"423","volume-title":"Diabetes in the NewMillenium","author":"SH Wilson","year":"1999","unstructured":"Wilson SH, Celermajer DS: Nitric oxide, cytokines and freeradicals in diabetic vascular disease. In Diabetes in the NewMillenium. Edited by Turtle J, et al. Sydney, Australia: PowerPublications; 1999:423\u2013432."},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/diabetes.49.7.1239","volume":"49","author":"JY Park","year":"2000","unstructured":"Park JY, Takahara N, Gabriele A, et al.: Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 2000, 49:1239\u20131248.","journal-title":"Diabetes"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/diabetes.49.9.1561","volume":"49","author":"P Quehenberger","year":"2000","unstructured":"Quehenberger P, Bierhaus A, Fasching P, et al.: Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes 2000, 49:1561\u20131570.","journal-title":"Diabetes"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"45021","DOI":"10.1074\/jbc.M307878200","volume":"278","author":"H Chen","year":"2003","unstructured":"Chen H, Montagnani M, Funahashi T, et al.: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278:45021\u201345026. Provides clear information on adiponectin and insulin signaling pathways.","journal-title":"J Biol Chem"},{"key":"19_CR27","first-page":"327","volume-title":"Diabetes in the New Millenium","author":"KSL Lam","year":"1999","unstructured":"Lam KSL: Dyslipidaemia and prothrombotic tendency in type 2 diabetes. In Diabetes in the New Millenium. Edited by Turtle J, et al. Sydney, Australia: Power Publications; 1999:327\u2013335."},{"key":"19_CR28","first-page":"3212","volume":"84","author":"KCB Tan","year":"1999","unstructured":"Tan KCB, Ai VHG, Chow WS, et al.: Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 1999, 84:3212\u20133215.","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridhar PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135\u20131143.","journal-title":"Circulation"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","volume":"24","author":"Y Matsuzawa","year":"2004","unstructured":"Matsuzawa Y, Funahashi T, Kihra S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004, 24:29\u201333. A key reference on the role of adiponectin in the metabolic syndromeand cardiovascular diseases.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1210\/jc.2003-032023","volume":"89","author":"KSL Lam","year":"2004","unstructured":"Lam KSL, Xu A, Tan KCB, et al.: Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab 2004, 89:5448\u20135453.","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Lamon J, Minokoshi Y, et al.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2001, 8:1288\u20131295.","journal-title":"Nat Med"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","volume":"8","author":"N Maeda","year":"2002","unstructured":"Maeda N, Shimomura I, Kishida K, et al.: Diet induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med 2002, 8:731\u2013737.","journal-title":"Nat Med"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, et al.: The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver disease in mice. J Clin Invest 2003, 112:91\u2013100.","journal-title":"J Clin Invest"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/en.2003-1140","volume":"145","author":"A Xu","year":"2004","unstructured":"XuA, Yin S, Wong LC, et al.: Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice. Endocrinology 2004, 145:487\u2013494. A good reference on the effects of adiponectin on lipid metabolism.","journal-title":"Endocrinology"},{"key":"19_CR36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00125-003-1224-3","volume":"46","author":"Y Hattori","year":"2003","unstructured":"Hattori Y, Suzuki M, Hattori S, Kasai K: Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003, 46:1543\u20131549.","journal-title":"Diabetologia"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.01.049","volume":"315","author":"H Motoshima","year":"2004","unstructured":"MotoshimaH, Wu XD, Mahadev K, Goldstein BJ: Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004, 315:264\u2013271. The first report on the antioxidant property of adiponectin.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR38","unstructured":"Xu A, Hoo RCL, Lam MCW, et al.: Adenovirus-mediatedexpression of adiponectin alleviates endothelial dysfunctionand oxidative stress associated with db\/db diabetic mice. Paper presented at the 87th Annual Meeting of the EndocrineSociety. San Diego, CA; June 4\u20137, 2005."},{"key":"19_CR39","first-page":"1999","volume":"321","author":"J Danesh","year":"2000","unstructured":"Danesh J, Whincup P, Walker M, et al.: Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis. BMJ 2000, 321:1999\u20131204.","journal-title":"BMJ"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem.87.2.8249","volume":"87","author":"KCB Tan","year":"2002","unstructured":"Tan KCB, Chow WS, Tam SCF, et al.: Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 2002, 87:563\u2013568.","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbrc.2004.09.177","volume":"324","author":"JM Cacicedo","year":"2004","unstructured":"Cacicedo JM, Yagihashi N, Keaney JF Jr, et al.: AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 2004, 324:1204\u20131209.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yan Q, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821\u20131830.","journal-title":"J Clin Invest"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","volume":"106","author":"Y Okamoto","year":"2002","unstructured":"Okamoto Y, Kihara S, Ouchi N, et al.: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106:2767\u20132770.","journal-title":"Circulation"},{"key":"19_CR44","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","volume":"100","author":"N Ouchi","year":"1999","unstructured":"Ouchi N, Kihara S, Arita Y, et al.: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473\u20132476.","journal-title":"Circulation"},{"key":"19_CR45","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","volume":"102","author":"N Ouchi","year":"2000","unstructured":"OuchiN, Kihara S, Arita Y, et al.: Adiponectin, an adipocytederived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296\u20131301. A key study on the anti-inflammatory action of adiponectin.","journal-title":"Circulation"},{"key":"19_CR46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-291X(03)00090-1","volume":"301","author":"M Fasshauer","year":"2003","unstructured":"Fasshauer M, Kralisch S, Klier M, et al.: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003, 301:1045\u20131050.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2003.12.104","volume":"314","author":"D Kawanami","year":"2004","unstructured":"Kawanami D, Maemura K, Takeda N, et al.: Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interaction. Biochem Biophys Res Commun 2004, 314:415\u2013419.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1056-8727(02)00259-3","volume":"18","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A: Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents. J Diabetes Complications 2004, 18:91\u2013102.","journal-title":"J Diabetes Complications"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-005-0019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-005-0019-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-005-0019-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:56:13Z","timestamp":1559418973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-005-0019-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s11892-005-0019-y","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}